Skip to main content

European Forum of National Psychedelic Societies – Key Presentations

On 7 May 2026, PAREA convened the first European Forum of National Psychedelic Societies in Brussels, bringing together representatives from organisations in 25 countries working on psychedelic research, policy, and access across Europe. Watch key presentations on the state of psychedelic access in Europe, filmed by Drugreporter.
European Forum of National Psychedelic Societies – Key Presentations

On 7 May 2026, PAREA convened the first European Forum of National Psychedelic Societies in Brussels, bringing together representatives from organisations in 25 countries working on psychedelic research, policy, and access across Europe. Watch key presentations on the state of psychedelic access in Europe, filmed by Drugreporter.

Held as a closed, invitation-only meeting, the Forum created a structured space for exchange, coordination, and peer learning among organisations advancing safe, regulated, and equitable access to psychedelic therapies within healthcare systems.

The gathering followed an event at the European Parliament on enabling psychedelic research for mental health in Ukraine and reflected a growing momentum for collaboration across the European psychedelic policy and research landscape. Watch some of the key presentations below:

Opening the European Forum of National Psychedelic Societies | Tadeusz Hawrot

Psychedelics: Access Models and Regulatory Developments in Germany | Gerhard Gründer

The Psychedelic Trojan Horse – Ketamine Implementation in Norway | Lowan Stewart

Psychedelics: A Case Study from Switzerland | Federico Seragnoli

Right to Relief – Compassionate Use Program with Psilocybin in Belgium | Adriana Zimbru

Psychedelics: A Case Study from Spain | Antón Gómez-Escolar

Filmed by István Gábor Takács, Drugreporter


©